From Name

From Email

To Name

To Email

Message

Pfizer to make Gilead's COVID-19 treatment remdesivir

from Cape Breton Post

Pfizer to make Gilead's COVID-19 treatment remdesivir Cape Breton Post Pfizer recently said it signed a multiyear agreement to make COVID-19 treatment remdesivir for developer Gilead Sciences Inc, which is under pressure to increase tight supplies of the antiviral drug. Gilead is aiming to make enough of the drug by the end of the year to treat more than two million COVID-19 patients, and agreed to send nearly all of its remdesivir supply to the United States through September. READ MORE

more